Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Auryxia: Global Drug Analysis (2015-2017) with Forecasts to 2024 - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Drug Analysis: Auryxia" drug pipelines has been added to ResearchAndMarkets.com's offering.

Auryxia (ferric citrate; Keryx Biopharmaceuticals/Japan Tobacco/Torii Pharmaceutical) is a novel oral ferric iron form with hematinic activity, approved for the treatment of anemia in chronic kidney disease. The drug dissociates into ferric iron and citrate after administration. Ferric iron is transported to erythroid precursor cells to be incorporated into hemoglobin, and also binds dietary phosphate in the gastrointestinal tract, precipitating as ferric phosphate. This compound is excreted, decreasing the phosphate concentration in the serum.

Key Topics Covered:

Product Profiles

Auryxia: Anemia in chronic kidney disease

List of Figures

Figure 1: Auryxia for anemia in chronic kidney disease - SWOT analysis

Figure 2: Drug assessment summary of Auryxia for anemia in chronic kidney disease (1)

Figure 3: Drug assessment summary of Auryxia for anemia in chronic kidney disease (2)

Figure 4: Auryxia sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country, 2015-24

List of Tables

Table 1: Auryxia drug profile

Table 2: Auryxia Phase III data in anemia in chronic kidney disease

Table 3: Auryxia Phase II data in anemia in chronic kidney disease

Table 4: Auryxia sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country ($m), 2015-24

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ttpdw5/auryxia_global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215005816/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.